-The Hindu This month marks the introduction of the Sustainable Development Goals (SDGs), which aim to dramatically improve lives across the world by 2030. This month marks the introduction of the Sustainable Development Goals (SDGs), which aim to dramatically improve lives across the world by 2030. The SDGs will help countries frame their policies and strategies towards achieving these mutually agreed upon goals and targets. SDG 3, which aims to ensure good...

-The Hindu Business Line Timely interventions through medical innovations can transform the lives of mothers and children, not simply save them A couple of years ago, I was in a primary health centre delivery room in Shivgarh and saw a beaming mother with her three-hour-old baby girl happily feeding at the breast. Three hours earlier, this contented baby was born without a cry, still, and blue in colour. Fortunately, the midwife present,...

-The Telegraph New Delhi: The Union health ministry will on Thursday launch the third phase of a vaccination campaign to cover an estimated 36 lakh children in 216 districts across India who have never received Vaccines or remain partially immunised. The campaign designed to immunise children against seven vaccine-preventable diseases - diphtheria, whooping cough, tetanus, polio, tuberculosis, measles and hepatitis-B - will focus on areas dogged by irregular or poor routine immunisation...

-The Hindu India’s UIP will now be able to provide free Vaccines against 13 life-threatening diseases to 27 million children annually India has made huge strides as far as public health achievements are concerned, made possible by the use of safe and effective Vaccines delivered through quality programmes. For example, small pox was eliminated in 1975, polio in 2014 and maternal and neonatal tetanus (MNT) in August 2015. While India has shown its...

-The Telegraph New Delhi: International humanitarian agency Medecins Sans Frontieres has filed an application to block US pharmaceutical company Pfizer from obtaining a patent in India for a vaccine against pneumonia and allow Indian vaccine manufacturers to make low-cost versions. The patent opposition moved by MSF has claimed that Pfizer's patent application, which describes methods of conjugating 13 serotypes (strains) of the bacterium Streptococcus pneumoniae into a single carrier vaccine, does not...